BRAF and mucosal melanoma: Survival analysis showed that an elevated baseline NLR was independently and significantly associated with an increased risk of death and disease progression in patients with either mucosal melanoma or non-mucosal melanoma, regardless of the mutation status of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene.